Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis: A Randomized Clinical Trial.

Saccà F, Gialdini G, Howard JF, Vu TH, Meisel A, Peric S, Lünemann JD, Sgarzi M, Shaibani A, Bril V, Yeh JH, Reyes-Garrido V, Liao S, Metais C, van der Valk RJP, ALXN2050-MG-201 Investigators.

Open source

DOI
10.1001/jamaneurol.2026.0902
Published
2026-06-01
Container
JAMA Neurol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamaneurol.2026.0902,
  title = {Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis: A Randomized Clinical Trial.},
  author = {Saccà F and  Gialdini G and  Howard JF and  Vu TH and  Meisel A and  Peric S and  Lünemann JD and  Sgarzi M and  Shaibani A and  Bril V and  Yeh JH and  Reyes-Garrido V and  Liao S and  Metais C and  van der Valk RJP and  ALXN2050-MG-201 Investigators.},
  year = {2026},
  journal = {JAMA Neurol},
  doi = {10.1001/jamaneurol.2026.0902},
  url = {https://doi.org/10.1001/jamaneurol.2026.0902}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis: A Randomized Clinical Trial.
AU  - Saccà F
AU  -  Gialdini G
AU  -  Howard JF
AU  -  Vu TH
AU  -  Meisel A
AU  -  Peric S
AU  -  Lünemann JD
AU  -  Sgarzi M
AU  -  Shaibani A
AU  -  Bril V
AU  -  Yeh JH
AU  -  Reyes-Garrido V
AU  -  Liao S
AU  -  Metais C
AU  -  van der Valk RJP
AU  -  ALXN2050-MG-201 Investigators.
PY  - 2026
JO  - JAMA Neurol
DO  - 10.1001/jamaneurol.2026.0902
UR  - https://doi.org/10.1001/jamaneurol.2026.0902
ER  - 

APA

F, S., G, G., JF, H., TH, V., A, M., S, P., JD, L., M, S., A, S., V, B., JH, Y., V, R., S, L., C, M., RJP, V. D. V., & Investigators., A. (2026). Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis: A Randomized Clinical Trial.. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2026.0902

Source records